SEPTInvestingStart Free

NXL SCHEDULE 13D/A: Material agreement

GreenLight Ventures, LLC

Filed with the SEC on · accession 0001829126-26-012395

NXL filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 13, 2026. GreenLight Ventures, LLC filed an amended Schedule 13D reporting beneficial ownership of 133,475 shares (approximately 10.8%) of Nexalin Technology, issued as consideration for the sale of PONM, Inc. under a May 2026 Stock Purchase Agreement, including 87,301 third-tranche shares issued November… The stock moved +0.0% by the first close after the filing.

Summary of the filing

GreenLight Ventures, LLC filed an amended Schedule 13D reporting beneficial ownership of 133,475 shares (approximately 10.8%) of Nexalin Technology, issued as consideration for the sale of PONM, Inc. under a May 2026 Stock Purchase Agreement, including 87,301 third-tranche shares issued November 10, 2026.

For details, click here →

Key details

Total value of Consideration Shares under the Stock Purchase Agreement$1.3M
Monthly consulting fee under the Collaboration Agreement$10K
Price per share of the October 20, 2026 issuance triggering anti-dilution adjustment$3
Reporting person / beneficial owner of ~10.8% of nexalin common stockGreenLight Ventures, LLC
Issuer / subject companyNexalin Technology, Inc.
Sold by greenlight ventures to nexalin technology as consideration for the sharesPONM, Inc.
Managing partner, greenlight ventures llcPeter Gratale
Director and chief medical officer of nexalin technologyDavid Owens

How NXL stock reacted

Close before

$1.49

Nov 12, 2026

First close after

+0.00%

$1.49

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for NXL, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NXL?

Click here

Frequently asked questions

What did NXL file with the SEC on Nov 13, 2026?

NXL filed a SCHEDULE 13D/A (Material agreement). GreenLight Ventures, LLC filed an amended Schedule 13D reporting beneficial ownership of 133,475 shares (approximately 10.8%) of Nexalin Technology, issued as consideration for the sale of PONM, Inc. under a May 2026 Stock Purchase Agreement, including 87,301 third-tranche shares issued November 10, 2026.

What does a material agreement mean for NXL stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did NXL stock react to this filing?

NXL closed at $1.49 before the filing and $1.49 on Nov 13, 2026 (+0.00%).

Other NXL SEC filings

Get alerts when NXL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
NXL overviewNXL analysisNXL newsLatest SEC filings